Evommune, Inc. Common Stock (EVMN)

Cash & Equivalents

$60.03M

Quarterly · Period ending: · USD

EVMN logo

EVMN Cash & Equivalents

Latest reported$44.06M
EVMN FY Cash & Equivalents ($29.02M → $44.06M)
High-resolution chart · PNG

EVMN cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
44,063,000
16,254,999
29,024,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.